ALLMedicine™ Zollinger-Ellison Syndrome Center

Jan 25th, 2023 - This protocol concerns the approach to the localization and management of the tumor in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor.

Jan 20th, 2023 - Study Description: Patients with confirmed, suspected or at risk of developing parathyroid disorders will be provided standard of care testing for their condition. Data obtained during the testing will be used for research. Additionally, samples m...

Nov 28th, 2022 - Gastrinoma with Zollinger-Ellison syndrome (ZES) may occur sporadically (Sp) or as part of the inherited syndrome of multiple endocrine neoplasia 1 (MEN-1). Data comparing Sp and MEN-1/ZES are scanty. We aimed to identify and compare their clinica...

Nov 3rd, 2022 - The Zollinger-Ellison Syndrome.|2022|Binet Q,Borbath I,|complications,diagnosis,

Sep 29th, 2022 - Non-functioning gastrin-producing neuroendocrine neoplasms (NEN) of the duodenum are rare gastrointestinal tumors without a clinical syndrome due to gastrin production. Their incidence has significantly increased as an incidental finding during en...

Jan 25th, 2023 - This protocol concerns the approach to the localization and management of the tumor in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor.

Jan 20th, 2023 - Study Description: Patients with confirmed, suspected or at risk of developing parathyroid disorders will be provided standard of care testing for their condition. Data obtained during the testing will be used for research. Additionally, samples m...

Jan 29th, 2021 - This study will evaluate whether treatment with YF476 is safe and effective in reducing the size of type II gastric carcinoid tumours, or limiting the abnormal growth of gastric ECL cells, in patients with Zollinger-Ellison syndrome.

Jan 7th, 2021 - The key aspects in the pathophysiology of pre-eclampsia are placental oxidative stress (and hypoxia), placental release of the anti-angiogenic factors Soluble Fms Like Tyrosine Kinase -1 and soluble endoglin and maternal endothelial dysfunction. A...

Sep 6th, 2018 - Critically ill patients who is able to receive early enteral nutrition and estimated to stay in ICU at least four days are considered to enroll into this study. Exclusion criteria are age under 18 or over 80 years, pregnancy or breastfeeding, know...

Apr 2nd, 2021 - Transcript: Simron Singh, MD: So Jon, we talked a bit about the patients who present with functional NETs [neuroendocrine tumors] or symptoms. What are some of the hormones that cause the symptoms you see in patients with neuroendocrine cancer...

Dec 20th, 2020 - Richard R.P. Warner, MD The Early Years: Piecing Together Evidence At age 89, I could probably earn the Guinness World Record for the oldest neuroendocrine cancer clinician in the United States, and perhaps even the world. I retired from clinica...

Dec 5th, 2020 - Sir Murray F. Brennan, MD Sir Murray F. Brennan, MD, thought he was joining an empirical science when he began medical school in 1960, but by the time he had completed his residency, he realized that surgery was actually a mishmash of tradition a...

Oct 25th, 2019 - My Take: It's Time for a Change. Do You Agree? The patient may not like it, but it's worth at least trying to taper his PPI at this time, with a goal of stopping regular PPI dosing altogether. Like many others, this patient is using his PPI as chr...

May 22nd, 2019 - SAN DIEGO — Prescriptions for proton pump inhibitors (PPIs) have skyrocketed over the past 2 decades, along with concerns about inappropriate use and adverse events. Prescriptions for PPIs went from 1.6% of ambulatory care visits in 1998 to 7.6% i...